ResMed | Omløpsmidler



Current Assets Endring Dato
Ansell USD 1.62B 732.9M 2024-06
AtriCure USD 267.83M 1.46M 2024-12
Baxter International USD 8.85B 11M 2024-12
Cochlear AUD 1.45B 124.7M 2024-06
Cooper Companies USD 1.99B 35.5M 2025-01
CSL USD 10.77B 622M 2024-06
Dexcom USD 4.3B 38.6M 2024-12
Edwards Lifesciences USD 6.29B 442.3M 2024-12
Fisher Paykel Healthcare NZD 767.9M 63M 2024-09
Globus Medical USD 2.18B 120.73M 2024-12
Haemonetics USD 1.01B 49.97M 2024-12
Hologic USD 3.49B 329.7M 2024-12
Idexx Laboratories USD 1.4B 33.85M 2024-12
Insulet USD 1.89B 30.4M 2024-12
Integra LifeSciences USD 1.08B 17.84M 2024-12
Intuitive Surgical USD 11.54B 4.33B 2024-12
Masimo USD 1.23B 54.1M 2024-12
Medtronic USD 22.51B 75M 2025-01
Philips EUR 10.02B 116M 2024-12
Ramsay Health Care AUD 3.41B 465.3M 2024-12
ResMed USD 2.84B 195.05M 2024-12
Sigma Healthcare AUD 1.22B 310.88M 2024-07
Sonic Healthcare AUD 2.3B 52.76M 2024-12
Steris USD 1.9B 40.02M 2024-12
Teleflex USD 1.47B 28.18M 2024-12
Thermo Fisher Scientific USD 22.14B 1.65B 2024-12



ResMed Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.